BRST5:Inflammatory myofibroblastic tumour: Difference between revisions
| [checked revision] | [checked revision] |
Kgeiersbach (talk | contribs) No edit summary |
Kgeiersbach (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<br /> | <br /> | ||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
Katherine Geiersbach, MD | Katherine Geiersbach, MD, Mayo Clinic - Rochester, MN, USA | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||
<span style="color:#0070C0">(''Instructions: This table’s content from the WHO book will be <u>autocompleted</u>.'')</span> | <span style="color:#0070C0">(''Instructions: This table’s content from the WHO book will be <u>autocompleted</u>.'')</span> | ||